For vitreoretinal surgeons, the management of Rhegmatogenous Retinal Detachment (RRD) is a constant balancing act of timing and technique. One of our most significant challenges is accurately determining the duration of the detachment, which directly influences surgical urgency, visual prognosis, and the potential need for adjunctive tools to manage proliferative vitreoretinopathy (PVR).
While we traditionally rely on patient history and OCT, these methods can be subjective or limited in scope. Recent research from Dr. Avni Finn and colleagues, published in Ophthalmology Science, suggests that Ultra Wide-Field (UWF) Fundus Autofluorescence (FAF) may provide the objective biomarkers we need to more precisely gauge detachment chronicity.
The Role of FAF in Surgical Triage
The study defined acute RRD as <2 weeks and chronic RRD as >2 weeks. By utilizing UWF imaging (such as Optos or Zeiss Clarus), surgeons can visualize peripheral pathology and identify specific patterns that correlate with these timelines.
Key findings from the research highlight two primary FAF biomarkers:
- The Hyperautofluorescent Leading Edge (Acute Indicator): A bright, hyperautofluorescent signal at the leading edge of a detachment is strongly associated with acute cases. Pathophysiologically, this represents RPE stress. These cells are “unwell” but likely still viable, suggesting a window of opportunity where prompt surgical intervention could save vision before permanent cell loss occurs.
- Hyperautofluorescent Dots (Chronic Indicator): Conversely, the presence of small, punctate hyperautofluorescent dots within the detached area is a marker of chronicity (>2 weeks). These dots likely represent the accumulation of exudates, lipids, or deposits resulting from impaired phagocytosis in areas where fluid has been sitting for an extended period.
A New Tool for Complex Presentations
FAF also provides clarity in bullous detachments, which often present with uniform hypoautofluorescence across the bullous area—likely due to blockage from the elevation—even in acute stages.
Integrating these imaging findings allows for more nuanced decision-making. For instance, if a patient is unsure of their symptom onset but FAF reveals a hyperautofluorescent leading edge, the surgeon may be more inclined to prioritize the case for emergent surgery to rescue stressed photoreceptors. Alternatively, the presence of chronic markers like hyperautofluorescent dots can help manage expectations regarding visual prognosis, particularly in macula-off cases.
Future Directions
As we continue to push the boundaries of multimodal imaging, the next step is correlating these FAF biomarkers with OCT findings. This will be especially valuable in clinics where UWF FAF may not be readily available, providing a standardized framework for triaging RRD based on objective retinal health indicators.
Reference: Finn, A. et al. (2026). Ultra Wide-Field Fundus Autofluorescence Findings as an Indicator of Duration in Rhegmatogenous Retinal Detachment. Ophthalmology Science.
